Denifanstat not checked

Ascletis · ASC40 · TVB-2640

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
1 active
13 in total · 1 in the EU
Targets
 

What this is

How it works
How it works isn't classified yet
Tested for
Acne Vulgaris
Main trialPhase 3
“The purpose of this study is to evaluate the safety and efficacy of denifanstat compared with matching placebo in participants with moderate to severe acne vulgaris who are ≥12 years of age. After the 12-week treatment phase, a subset of approximately 530 participants will have the option to consent to an open-label extension phase for an additional 40 weeks of treatment.”In the company’s words, NCT07863193 on ClinicalTrials.gov
Other names
ASC40 · TVB-2640

Other drugs for Acne Vulgaris

All 14 drugs for Acne Vulgaris

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials13

TrialPhaseCompletesWhat it tests
Phase 3Recruiting Aug 2027 Phase 3 Study of Denifanstat in Participants With Moderate to Severe Acne (AURORA)
Phase 3Completed 19 May 2025 A Study to Evaluate the Safety and Efficacy of ASC40 (Denifanstat) Tablets in the Treatment of Patients With Moderate to Severe Acne Vulgaris
Phase 3Unknown Jun 2025 Study to Evaluate the Safety and Efficacy of ASC40 Tablets in Combination With Bevacizumab in Subjects With rGBM
Phase 3Completed 12 Nov 2025 A Study to Evaluate Safety of ASC40 Tablets in Patients With Moderate to Severe Acne Vulgaris
Phase 3Withdrawn Jun 2026 A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASLD and MASH
Phase 3Withdrawn Dec 2030 A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASH and F2/F3 Fibrosis
Phase 2Completed 2 Oct 2021 Study of TVB-2640 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Phase 2Completed 10 Apr 2023 Study to Evaluate the Safety and Efficacy of ASC40 in Subjects With Moderate to Severe Acne Vulgaris
Phase 2Completed 2 Oct 2023 Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Phase 1Completed 6 May 2021 Study to Evaluate the Effects of Itraconazole and Rifampin on the Pharmacokinetics of ASC40 in Healthy Subjects
Phase 1Completed 21 Dec 2022 Open-label Study of the Absorption, Metabolism, and Excretion of [14C]TVB-2640 Following a Single Oral Dose in Healthy Male Subjects
Phase 1Completed 18 Dec 2023 A Phase I Pharmacokinetic Study of TVB-2640 (Denifanstat) in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic Function
Phase 1Completed 20 Oct 2025 A Drug-Drug Interaction Study of Denifanstat and Resmetirom in Healthy Adult Participants
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow Denifanstat

Following is part of Solo: you see every change to Denifanstat the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in